Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Case of Nodular Rash & Painful Joints

Vania Lin, MD, MPH, Rebecca Johnson, MD, & Lisa Suter, MD  |  Issue: October 2022  |  October 10, 2022

FIGURE 1: The patient presented with an erythematous, tender, nodular rash overlying both of his lower extremities and lower abdomen. (Click to enlarge.)

Polyarteritis nodosa (PAN) is a necrotizing vasculitis, predominantly involving medium-sized arteries, that causes systemic disease, and, less commonly, cutaneous-limited disease. The population prevalence for PAN ranges from 2 to 33 per million.1-3 Estimates vary due to the increased recognition and classification of other forms of vasculitides over time and variation in the regional prevalence of hepatitis B virus infection, a disease that is closely associated with PAN. Cutaneous PAN accounts for approximately 4% of all cases of PAN.4

Here, we present a case of cutaneous PAN with antecedent group A Streptococcal infection, treated with non-steroidal anti-inflammatory drugs (NSAIDs), colchicine, prednisone and antibiotics.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Case Description

A 22-year-old man with a past medical history of gastric sleeve surgery and active tobacco use presented with a painful rash and polyarthralgia. His rash had started four weeks before on the sole of his left foot and spread in an ascending manner, involving both lower extremities, his groin region and abdomen. He developed swelling and pain in his left knee two weeks before and pain in his bilateral elbows two days before presentation. He was febrile up to 102.8ºF (39.3ºC) the first night of his hospitalization, although the patient did not mention having a fever while at home.

The patient stated that a punch biopsy of his left calf rash had been performed by a community dermatologist a few days earlier. The tissue sample contained a muscular blood vessel associated with a mixed inflammatory infiltrate including neutrophils and eosinophils; fibrinoid and basophilic material within the lumen of the blood vessel and fibrosis were noted. The interpretation was of medium vessel vasculitis, suggestive of PAN, with differential diagnosis including anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis and vasculitis caused by another rheumatic disease, less likely erythema induratum. The patient had been directed to come to the hospital for further evaluation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The patient did not recall any preceding acute illnesses, vaccinations, animal or insect bites, travel or sick contacts. He denied any history of skin, joint, gastrointestinal, autoimmune or sexually transmitted diseases. He reported being predominantly indoors for work, though he occasionally did yard work at home. He had been taking NSAIDs, acetaminophen and tramadol for his symptoms with limited effect; he otherwise did not regularly take medications.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:case reportFellowsFellows Forumpolyarteritis nodosa

Related Articles

    Case Report: Diagnosing, Treating Hepatitis B-Linked Polyarteritis Nodosa

    September 17, 2019

    Hepatitis B virus (HBV) associated polyarteritis nodosa (PAN) is an increasingly rare vasculitis in developed countries due to advances in HBV vaccination and antiviral therapy. However, the condition does persist, and rheumatologists should consider it when evaluating vasculitis cases. Below, we discuss a case that illustrates the varied clinical presentations PAN can encompass. A high…

    Medium-sized blood vessels are seen in the dermis and at the dermal-subcutaneous junction. The black arrow identifies a venule, and the blue arrow points to a fibrin deposition in the vessel wall. Extravasated neutrophils and erythrocytes are seen in the interstitium.

    Case Report: A Polyarteritis Nodosa Conundrum

    March 14, 2022

    Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis that typically affects medium-sized muscular arteries. The clinical subsets of PAN are idiopathic, generalized, secondary hepatitis B virus (HBV) associated and cutaneous PAN. These clinical subsets are important because of their therapeutic implications. Virtually any organ system can be affected in generalized PAN, but this vasculitis tends…

    Vasculitis Guidelines in Focus, Part 4: Polyarteritis Nodosa

    September 22, 2021

    Jason Springer, MD, MS, served as one of the lead authors of the ACR/VF guidelines for polyarteritis nodosa (PAN), and talks about the recommendations specific to PAN here.

    Alisusha; Trueffelpix / shutterstock.com

    3 New Vasculitis Guidelines Discussed

    May 13, 2021

    The ACR, in concert with the Vasculitis Foundation, released three new vasculitis guidelines online first in July, with a fourth slated for publication by the end of the year. These are the first ever to be produced and endorsed by the ACR and the Vasculitis Foundation. Although most of the recommendations are conditional, due to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences